Hot on the heels of a £4m Horizon 2020 grant, the Company concluded a couple of major pharma deals and opened it’s first overseas office. Back in December 2017, TCB announced a strategic collaboration with Boston-based Bluebird Bio to develop gamma-delta CAR-T products for both solid and haematological cancers, commercial terms included a £14 million upfront payment, subsequent potential R&D support and commercial milestone payments....
VETS Now, the out of hours emergency pet care and surgical specialist, has revealed plans to expand its network of veterinary hospitals around the UK, as it targets lifting turnover to nearly £50 million in its current financial year. The £1.5 million project, which is due for completion later this year, will add two further levels to the hospital on Glasgow’s North Street, including a...
Tokyo-based Terumo Corporation has today announced an investment of £33 million in one of its subsidiary companies, Vascutek Limited, located near Glasgow. The investment has been approved for the major expansion of Vascutek’s headquarters and manufacturing facility at Inchinnan, Renfrewshire to help drive further growth for the global medical device company. Vascutek produces a wide portfolio of implants with a particular focus on treating patients...
Health Data Research UK is awarding £30 million funding to six sites across the UK, including Scotland, to address challenging healthcare issues through use of data science. Each site has world-class expertise; a track record in using health data to derive new knowledge, scientific discovery and insight; and works in close partnership with NHS bodies and the public to translate research findings into benefits for...
Dundee University spin off company, MyWay Digital Health wins Digital Health Catalyst award of £1million from Innovate UK to develop a new artificial intelligence system to support clinicians and people with diabetes. The Innovate UK grant will be used to develop an artificial intelligence system that will give diabetes patients, and those treating them, automatic advice about their health. MyDiabetesIQ will use data to predict whether...
Following the Scotsman Life Sciences Conference on 21st November, Life Sciences Scotland have developed a new mini series to address key issues and business concerns raised through discussions at the event. The aim is to sign-post where to find information relevant to the industry. The first mini-series shared through social media began on the 11th December with a focus on Funding & Support available to...